Animal Biotechnology Market Size, Share, By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By Animal Type (Companion, Livestock), By End-user (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), and By Region - Trends, Analysis and Forecast till 2034

Animal Biotechnology Market Size was valued at USD 28.36 Billion in 2024 and is expected to reach USD 64.75 Billion by 2034, growing at a CAGR of 9.5%

Animal biotechnology is a broad field that aims to improve animals' traits, health, and productivity by applying biological and technical principles to them. This field includes cloning, genetic engineering, and assisted reproductive technologies, among other methods. Scientists modify the genomes of animals to produce transgenic animals with desired features, such as higher disease resistance or faster growth rates. Creating animal models of human diseases is another area of interest for this discipline, which supports both medication development and medical research. Furthermore, animal biotechnology is essential to conservation efforts since it uses embryo transfer and artificial insemination methods to protect endangered species. Animal welfare and the possible ecological effects of genetically modified organisms are two ethical issues the area poses, even though it offers enormous potential benefits in agriculture, medicine, and environmental conservation. Animal biotechnology is still a vibrant and contentious field at the nexus of science, ethics, and policy as research advances.